← All stocks

Processa Pharmaceuticals, Inc.

PCSA Net selling
CIK 0001533743 #5341 in the set updated 18 Sep 2026
Bought (120 mo)
$1.03M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.36M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$5.36M
11 of 11 sales
Net
−$4.33M
−$4.33M against sales at will

By person

15 insiders · 81 transactions
0.5×

George Ng holds only 0.5 times base salary in stock. $201.28K of shares against $400.00K in salary for 2025.

Salary from the company's own proxy. The shares are what George Ng last reported holding, valued at $1.93, the price Common Stock was last bought or sold at on the open market here, on 1 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
BESSER JAMES E
See Remarks
$121.20K (1)
$5.15M (6)
−$5.03M
2,178,300
$4.20M
−17.0%
Young David
Pres. Research & Development
$382.45K (16)
+$382.45K
82,044
$158.34K
Lin Patrick
Chief Business - Strategy Off
$226.26K (19)
+$226.26K
56,613
$109.26K
Yorke Justin W
Director
$31.43K (2)
$207.96K (5)
−$176.53K
261,025
$503.78K
+2.9%
Ng George K
Chief Executive Officer
$135.22K (9)
+$135.22K
104,292
$201.28K
SKIBSTED RUSSELL
Chief Financial Officer
$41.67K (7)
+$41.67K
16,689
$32.21K
Guy Wendy
Chief Administrative Officer
$32.91K (7)
+$32.91K
22,729
$43.87K
Stanker James H
Chief Financial Officer
$19.41K (2)
+$19.41K
6,482
$12.51K
Bigora Sian
Chief Development Officer
$16.03K (3)
+$16.03K
14,164
$27.34K
Floyd Robert Michael
Chief Operating Officer
$14.06K (1)
+$14.06K
186,118
$359.21K
+8.2%
Baluch Khoso
Director
$5.75K (1)
+$5.75K
2,528
$4.88K
Pannu Geraldine
Director
$5.25K (1)
+$5.25K
2,391
$4.61K
Neal James R
Director
$2.00K (1)
+$2.00K
1,021
$1.97K
THOMPSON VIRGIL
Director
221,378
$427.26K
+28.1%
Islam Khalid
Director
72,486
$139.90K
+6.4%

No percentages here. This company's share count has moved by a factor of 21.3 over the window, from 2,660,039 to 56,644,223 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 38
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 11
Transactions with no price 0
Shares from compensation/vesting 1,143,972
Sales filed before the plan box existed 11
History held since 5 Oct 2020